EUVIMEDObjevte EUVIMED
Crossref

Impact of catheter ablation on atrial fibrillation outcomes in various cardiomyopathies: findings from LGE-MRI quantified atrial fibrosis analysis

Ahmad Kassar, Nadia Chamoun, Romanos Haykal, Yaacoub Chahine, Hala Al Yasiri, Tori Hensley, David Owens, Nazem Akoum

Journal of Interventional Cardiac Electrophysiology · 2025

DOI: 10.1007/s10840-025-02027-6 ↗

At a glance

Journal article in Journal of Interventional Cardiac Electrophysiology, 2025. Written by Ahmad Kassar and 7 co-authors. Institution: Division of Cardiology, University of Washington, 1959 NE Pacific St, Seattle, WA, 98195, USA. Major MEDLINE topics: Atrial Fibrillation, Catheter Ablation, Cardiomyopathies, Heart Atria. Cited 6 times so far (Crossref); 43 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

BACKGROUND: Cardiomyopathy (CM) is associated with atrial remodeling and atrial fibrillation (AF), often complicating rhythm management. Ventricular dysfunction contributes to AF through pressure and volume overload, while AF worsens ventricular function via tachycardia and irregular activation. Evidence suggests catheter ablation improves outcomes in CM patients, though success is influenced by the extent of atrial and ventricular remodeling. METHODS: Patients undergoing their first catheter ablation for AF were divided into hypertrophic (HCM), ischemic (ICM), non-ischemic (NICM), and no-CM groups. Pre-ablation late-gadolinium enhancement cardiac magnetic imaging (LGE-MRI) was used to assess left atrial (LA) fibrosis burden and anatomical distribution. Patients were followed prospectively for arrhythmia recurrence. RESULTS: A total of 552 patients, 39 HCM (69% obstructive), 39 ICM, 115 with NICM, and 359 without CM were included between January 2015 and December 2022. LA fibrosis was significantly higher in patients with CM (19.1 ± 7.5% vs. 16.5 ± 6.9%; P = 0.01). HCM and ICM had the greatest LA fibrosis among the different CM subtypes (21.3 ± 8.7% and 21.9 ± 9.1%, respectively). There was no significant difference in the regional distribution of fibrosis among the various groups. AF recurrence was observed in 321 (58.2%) after 456 (175-1204) days. Multivariate analysis revealed that compared to no CM, HCM was associated with a three-fold increase in AF recurrence (HR = 3.07, 95% CI 2.06-4.58, P < 0.001), followed by ICM (HR 1.61, 95%, CI 0.95-2.72; P = 0.07) and NICM (HR of 1.53, 95% CI 1.14-2.06; P = 0.05). LA fibrosis and volume index were independently associated with recurrence (HR = 1.03, 95% CI 1.01-1.06, P = 0.01 and HR = 1.02, 95% CI 1.01-1.03, P = 0.01). Genetic testing revealed key distinctions between HCM and NICM, with MYBPC3 and MYH7 as prominent genes in HCM and a heterogeneous genetic basis in NICM. CONCLUSION: Hypertrophic cardiomyopathy is associated with the highest risk of AF recurrence followed by ischemic and non-ischemic cardiomyopathy after catheter ablation. LA fibrosis regional patterns did not differ between cardiomyopathy types, while overall fibrosis and volume predicted recurrence.

Subjects

MeSH terms (MEDLINE)

Atrial FibrillationCatheter AblationCardiomyopathiesHeart AtriaHumansFemaleMaleMiddle AgedFibrosisTreatment OutcomeMagnetic Resonance ImagingContrast MediaAgedRecurrenceAtrial RemodelingMagnetic Resonance Imaging, Cine

Author keywords

Atrial fibrillationAtrial fibrosisCardiomyopathyCatheter ablation

Substances

Contrast Media

Authors and institutions

  • Division of Cardiology, University of Washington, 1959 NE Pacific St, Seattle, WA, 98195, USA.
  • Department of Medicine, University of Washington, Seattle, WA, USA.
  • Division of Cardiology, University of Washington, 1959 NE Pacific St, Seattle, WA, 98195, USA. nakoum@cardiology.washington.edu.
  • Department of Bioengineering, University of Washington, 1959 NE Pacific St, Seattle, WA, 98195, USA. nakoum@cardiology.washington.edu.

Cite

APA

Kassar, A., Chamoun, N., Haykal, R., Chahine, Y., Al Yasiri, H., Hensley, T., Owens, D., & Akoum, N. (2025). Impact of catheter ablation on atrial fibrillation outcomes in various cardiomyopathies: findings from LGE-MRI quantified atrial fibrosis analysis. Journal of Interventional Cardiac Electrophysiology. https://doi.org/10.1007/s10840-025-02027-6

Vancouver

Kassar A, Chamoun N, Haykal R, Chahine Y, Al Yasiri H, Hensley T, et al. Impact of catheter ablation on atrial fibrillation outcomes in various cardiomyopathies: findings from LGE-MRI quantified atrial fibrosis analysis. Journal of Interventional Cardiac Electrophysiology. 2025. doi:10.1007/s10840-025-02027-6

BibTeX
@article{Kassar2025,
  author = {Kassar, Ahmad and Chamoun, Nadia and Haykal, Romanos and Chahine, Yaacoub and Al Yasiri, Hala and Hensley, Tori and Owens, David and Akoum, Nazem},
  title = {Impact of catheter ablation on atrial fibrillation outcomes in various cardiomyopathies: findings from LGE-MRI quantified atrial fibrosis analysis},
  journal = {Journal of Interventional Cardiac Electrophysiology},
  year = {2025},
  doi = {10.1007/s10840-025-02027-6}
}
Start for free →